Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: Gastric adenocarsinoma is the first leading fatal malignancy in Iran. Despite
advances in novel therapeutics approaches for gastric cancer (GC)
patient, tumor dissemination via blood stream to distant organ is still the
major cause of death. Therefore, there is urgent need to establish sensitive
methods for early detection of disseminated tumor cells in peripheral blood (PB)
and bone marrow (BM) specimens of gastric
cancer patients.
Methods: In the present study, we use Carcinoma Embryonic Antigen (CEA)
as a tumor marker and Glyceraldehyde 3-Phosphate
Dehydrogenase (GAPDH) as an internal
control to detection and quantification of disseminated tumor cells in PB
and BM specimens of affected individuals. Total RNA
was extracted from AGS (gastric cancer)
cell line and CEA and GAPDH
fragments were generated by reverse transcription. The amplified fragments were
cloned into pTZ57R/T vector separately.
Double cloning of these genes has done into one pTZ57R/T
vector. Serial dilution of this recombinant plasmid is used to construct
standard curve, each containing a known amount of input copy number. Total RNA
was extracted from BP and BM
specimens of 35 GC patients. cDNA
of the specimens were synthesized by reverse transcription and subjected to Quantitative
Real-Time
PCR (QRT-PCR).
Results: We developed a highly sensitive and specific quantitative PCR
for CEA and GAPDH
using Real-Time
PCR based on TaqMan
technology. CEA mRNA
was detected in 23% of PB
and 20% of BM
specimens. There was no CEA mRNA
detecting in control group.
Conclusions: The QRT-PCR for CEA
can be a useful technique for detection of micrometastases in the PB
and BM specimens of gastric cancer patients.
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |